ds like catheterization to empty the bladder and/or surgery. Tamsulosin-DRS can address a substantial market for BPH in dysphagic patients Veru's Tamsulosin-DRS is its Tamsulosin-XR (extended release formulation) in an oral suspension form. XR slows the release of Tamsulosin, thus reducing the chances of ov